Location History:
- Chuo, Tokyo, JA (1977)
- Koto-ku, Tokyo, JP (2003)
- Tokyo, JP (1988 - 2004)
Company Filing History:
1 out of 776 
1 out of 2 
2 out of 832,880 Years Active: 1977-2004
Title: Teruaki Sekine: Innovator in Cord Blood-Derived Therapies
Introduction
Teruaki Sekine is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the development of therapies derived from cord blood. With a total of 4 patents, his work focuses on innovative methods for preventing and treating various diseases.
Latest Patents
Sekine's latest patents include groundbreaking inventions such as "Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations." This invention highlights the effectiveness of activated lymphocytes derived from cord blood in preventing and treating tumors and infections. The method involves segregating lymphocytes from cord blood and proliferating them in vitro, which can also aid in preventing disease recurrence and promoting the acceptance of stem cells or other organs. Another notable patent is "Compositions comprising, as the main ingredient, allogenic activated-CD4+ cells and method for producing and using the same." This invention focuses on the use of allogenic activated-CD4+ cells for preventing tumor recidivism and treating various infections without causing serious graft-versus-host disease (GVHD).
Career Highlights
Throughout his career, Teruaki Sekine has worked with notable companies, including Kureha Kagaku Kogyo Kabushiki Kaisha. His innovative research has positioned him as a key figure in the field of regenerative medicine and immunotherapy.
Collaborations
Sekine has collaborated with esteemed colleagues such as Kiminari Ito and Kenzo Bamba. Their combined expertise has contributed to the advancement of therapies that leverage the potential of cord blood-derived cells.
Conclusion
Teruaki Sekine's contributions to medical science through his patents and collaborations have paved the way for innovative treatments that harness the power of cord blood. His work continues to inspire advancements in the field of regenerative medicine.